Company research / NAII

Natural Alternatives International Inc (NAII)

SEC name NATURAL ALTERNATIVES INTERNATIONAL INC · CIK 0000787253 · Nasdaq · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Natural Alternatives International Inc reported revenue of $142.51M. Revenue grew 9.7% from the prior annual period.

Key ratios (year ended 2026-06-30)

6.3%
Gross margin
-13.2%
Operating margin
-14.5%
Net margin
-41.4%
Return on year-end equity
9.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-K (annual report) · 2026-09-28

Headquarters locality: San Marcos · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$142.51M$129.86M$113.80M$154.01M$170.97M$178.52M$118.88M$138.29M$132.44M$121.95M
Cost of Revenue$133.52M$120.57M$106.93M$135.86M$140.46M$148.08M$100.00M$114.72M$106.12M$95.74M
Gross Profit$9.00M$9.29M$6.87M$18.16M$30.51M$30.44M$18.87M$23.57M$26.32M$26.20M
R&D Expense$2.30M$1.80M$1.90M$2.10M$2.50M$1.90M$1.80M$1.80M$1.50M$1.60M
Operating Income-$18.75M-$8.66M-$8.53M$4.71M$13.68M$13.67M-$1.51M$5.96M$9.53M$9.70M
Depreciation & Amortization$4.71M$4.56M$4.65M$4.25M$4.17M$4.34M$3.96M$3.46M$2.91M$2.38M
EBITDA-$14.04M-$4.10M-$3.89M$8.96M$17.84M$18.01M$2.45M$9.43M$12.44M$12.09M
Net Income-$20.70M-$13.57M-$7.22M$2.52M$10.71M$10.77M-$1.65M$6.54M$5.05M$7.24M
EPS (Diluted)-$3.43-$2.28-$1.23$0.43$1.74$1.69-$0.25$0.92$0.73$1.09
Total Assets$126.45M$151.94M$162.34M$134.15M$146.00M$120.28M$120.20M$93.49M$85.21M$72.61M
Total Liabilities$76.49M$83.51M$79.75M$45.38M$57.48M$40.20M$48.83M$17.41M$16.96M$11.46M
Long-Term Debtn/an/an/an/an/an/an/a$0$0$0
Shareholders' Equity$49.96M$68.43M$82.59M$88.77M$88.52M$80.08M$71.38M$76.08M$68.25M$61.15M
Cash & Equivalents$7.39M$12.32M$11.98M$13.60M$21.83M$32.13M$30.48M$25.04M$23.61M$27.84M
Operating Cash Flow-$8.92M$5.93M-$1.50M$7.02M$11.87M$20.81M$3.69M$6.56M$1.83M$14.14M
Capital Expenditures$3.70M$3.61M$3.02M$13.52M$26.49M$5.11M$4.54M$5.33M$4.08M$5.35M
Free Cash Flow-$12.62M$2.32M-$4.51M-$6.50M-$14.62M$15.70M-$850.0K$1.24M-$2.25M$8.78M
Share Repurchases$89.0K$178.0K$221.0K$1.50M$5.50M$4.15M$3.75M$1.37M$510.0K$712.0K
Shares Outstanding6.27M6.18M6.20M6.07M6.13M6.44M6.75M7.23M7.56M6.94M
Weighted Average Diluted Shares6.03M5.95M5.87M5.88M6.16M6.38M6.70M7.10M6.89M6.66M
EPS (Basic)-$3.43-$2.28-$1.23$0.43$1.75$1.71-$0.25$0.96$0.76$1.10

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView